Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle

Inventia Healthcare Limited has recalled Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on June 24, 2026 and was initiated on June 5, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.

What was recalled?

This recall covers Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, with approximately 11,460 bottles affected. The company behind the recall is Inventia Healthcare Limited, based in Kalyan. The FDA describes the product as: “Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 088…”

Why was Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle recalled?

According to the FDA, the stated reason for the recall is: “Failed Dissolution Specifications.” In plain terms, this recall relates to a potency or effectiveness issue.

This recall means the medicine may be stronger or weaker than its label says, or may not release its ingredient the way it should. That matters because too little medicine may not treat the condition, and too much can cause side effects. Anyone taking an affected product is generally advised to consult their pharmacist or doctor about a replacement.

What should you do?

If you think you may have bought Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, compare it against the product description and identifying codes ([100 tablet bottle] Batch RISA24001; [1000 tablet bottle] Batch RISB24002; Exp. 04/2027) before using it. This recall is currently listed as ongoing.

The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Inventia Healthcare Limited or your local health authority.

About this recall

This recall was distributed in U.S. Nationwide.. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.